Enter assignee name

Forward Citations = 170

Loading Chart...

6 inventors (with patents filed for the assignee):

Robert P Lanza (10 out of 54 patents)

Irina V Klimanskaya (7 out of 24 patents)

Erin Anne Kimbrel (2 out of 5 patents)

4. Jianlin Chu (2 out of 4 patents)

5. Nicholas Arthur Kouris (2 out of 4 patents)

6. Shi-Jiang Lu (1 out of 18 patents)

10 patents: Sort by Forward Citations

1. 9410123 - Hemangio colony forming cells and non-engrafting hemangio cells (2016-08-09),

2. 9193950 - Modalities for the treatment of degenerative diseases of the retina (2015-11-24),

3. 9181524 - Modalities for the treatment of degenerative diseases of the retina (2015-11-10),

4. 9080150 - Modalities for the treatment of degenerative diseases of the retina (2015-07-14),

5. 9045732 - Modalities for the treatment of degenerative diseases of the retina (2015-06-02),

6. 9040770 - Modalities for the treatment of degenerative diseases of the retina (2015-05-26),

7. 9040039 - Modalities for the treatment of degenerative diseases of the retina (2015-05-26),

8. 9040038 - Modalities for the treatment of degenerative diseases of the retina (2015-05-26),

9. 8962321 - Mesenchymal stromal cells and uses related thereto (2015-02-24),

10. 8961956 - Mesenchymal stromal cells and uses related thereto (2015-02-24),

Ocata Therapeutics, Inc. is a biotechnology company focused on the development and commercialization of regenerative medicine products to treat degenerative eye diseases. Their innovative technology platform allows for the production of high-quality, sustainable cell-based therapeutics to address unmet medical needs in ophthalmology. With a strong track record of success in clinical trials, Ocata Therapeutics is poised to revolutionize the treatment of vision-related conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

10 Patents

#39 in Marlborough, MA

#1,721 in Massachusetts

#28,957 in US

#54,287 in the World

Marlborough, MA, United States of America

Ocata Therapeutics, Inc.